Omnicell Inc (OMCL)

Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell

$30.04

Buy

$30.59

arrow-up$0.54 (+1.81%)

Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
Prices updated at 31 May 2025, 00:03 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
713m787m897m892m1,132m1,296m1,147m1,112m
319m372m437m413m555m589m497m471m
11m44m78m36m90m-2m-35m337,000
1.565.648.733.987.91-0.18-3.040.03
31m38m61m32m78m6m-20m13m
63m96m142m107m174m97m61m90m
Sales, General and administrative241m263m290m308m389m486m435m380m
Interest expenses--------
Provision for income taxes-26m-2m13m-3m-12m-8m263,00013m
Operating expenses307m328m359m378m465m591m532m471m
Income before taxes5m36m74m29m66m-2m-20m26m
Net income available to common shareholders31m38m61m32m78m6m-20m13m
0.550.961.480.761.790.13-0.450.27
Net interest income-7m-9m-4m-6m-23m-130,00015m25m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.530.931.430.741.620.12-0.450.27
Free cash flow per share0.41890.20382.30651.9774.2003-0.09563.66512.5794
Book value/share12.294415.352419.166721.466425.155325.373726.075126.5475
Debt equity ratio0.3516190.1992550.1190990.5334330.0348050.5361970.507650.158866

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets367m397m483m829m781m882m928m815m
Current liabilities213m205m237m276m876m428m368m596m
Total capital712m815m895m1,435m1,147m1,697m1,759m1,410m
Total debt210m135m111m528m541m617m614m383m
Total equity517m680m845m968m1,147m1,130m1,189m1,243m
Total non current liabilities--------
Loans195m135m50m467m-567m570m166m
Total assets980m1,081m1,241m1,825m2,142m2,211m2,227m2,121m
Total liabilities--------
Cash and cash equivalents32m67m127m486m349m330m468m369m
Common stock38m40m42m43m44m45m46m46m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period54m32m67m127m490m356m353m501m
Cash dividends paid--------
-6m50m83m131m173m17m126m135m
Investments (gains) losses-35m-54m-62m-280m-412m-59m-55m-53m
32m67m127m490m356m353m501m399m
Net income--------
25m104m145m186m232m78m181m188m
-31m-54m-62m-55m-58m-61m-55m-53m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.